
Fujifilm’s continuing global presence
New business ventures, new systems – and those include 3-D mammography

New business ventures, new systems – and those include 3-D mammography

Philips is showcasing the company’s mission of “Transforming Care Together” by featuring several of its latest solutions developed with customer insights in mind, demonstrating the company’s commitment to keeping pace with the changing needs of radiologists at RSNA.

Meeting with EH editor Brigitte Dinkloh, Congress Secretary Professor Alexis Ulrich MD (left), Assistant Medical Director at the Clinic for General, Visceral and Transplant Surgery at the University of Heidelberg, outlined the scientific programme, discussed some impressive advances in surgical procedures, and explained why the gathering bears the slogan Surgery in Partnership.

MRI: Although an area of constant debate, this is becoming a widely accepted clinical modality in Europe. However, researchers in The Netherlands have shown that performing pre-operative breast MRI in all women with invasive lobular carcinoma (ILC) can reduce the need for re-excision.

In Europe, 350,000 women are diagnosed with breast cancer annually. About 90% of them can be cured if the cancer is detected at a very early stage. To improve early detection almost all European countries have gradually initiated regional screening programmes, even though the benefits are discussed controversially from time to time.

This week, university hospital Klinikum rechts der Isar in Munich, Germany, is the first hospital in the world to operating Brainlab’s Curve Image Guided Surgery system. Curve is Brainlab’s latest generation of image-guided surgery systems. The new technology provides surgeons with better guidance and control during surgery enabling faster, more precise and safer interventions.

Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.

By Thomas Mertelmeier, Principal Scientist at Siemens AG Medical Solutions